154 related articles for article (PubMed ID: 7265520)
61. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
62. [Ductal cytometry of urinary sediment in the diagnosis of bladder cancer].
Bozhenko BK; Kaprin AD; Kulinich TM; Nesterov PV
Vopr Onkol; 2009; 55(3):278-84. PubMed ID: 19670726
[No Abstract] [Full Text] [Related]
63. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors].
Gregersen B; Mommsen S; Svanholm H
Ugeskr Laeger; 1999 Apr; 161(14):2071-3. PubMed ID: 10354792
[TBL] [Abstract][Full Text] [Related]
64. [Urinary bladder tumors. Report of the Danish Bladder-cancer Committee 1993].
Ugeskr Laeger; 1997; 159 Suppl 1():1-14. PubMed ID: 9273765
[No Abstract] [Full Text] [Related]
65. [Cytological examination of urinary bladder tumors in routine urologic practice].
Pazourek J
Rozhl Chir; 1982 Jan; 61(1):57-61. PubMed ID: 7063997
[No Abstract] [Full Text] [Related]
66. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
67. [Nonmalignant proliferative lesions of the urinary bladder].
Halachmi S; Moskovitz B; Madjar S; Nativ O
Harefuah; 1995 Dec; 129(11):516-9. PubMed ID: 8846966
[No Abstract] [Full Text] [Related]
68. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
Moonen PM; Kiemeney LA; Witjes JA
Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
[TBL] [Abstract][Full Text] [Related]
69. [Exfoliative cytology of the bladder tumor].
Inada T
Nihon Hinyokika Gakkai Zasshi; 1967 Feb; 58(2):156-75. PubMed ID: 6069873
[No Abstract] [Full Text] [Related]
70. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
Leyh H; Hall R; Mazeman E; Blumenstein BA
Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
[TBL] [Abstract][Full Text] [Related]
71. [Cytodiagnosis of bladder cancer].
Braxs A; Braxs J
Rev Fac Cienc Med Cordoba; 1966; 24(2):147-50. PubMed ID: 5965791
[No Abstract] [Full Text] [Related]
72. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
73. Conventional bladder wash cytology performed by four experts versus quantitative image analysis.
van der Poel HG; Boon ME; van Stratum P; Ooms EC; Wiener H; Debruyne FM; Witjes JA; Schalken JA; Murphy WM
Mod Pathol; 1997 Oct; 10(10):976-82. PubMed ID: 9346176
[TBL] [Abstract][Full Text] [Related]
74. [Contribution of pathology on diagnostic cytology. Relationship between histopathology and cytopathology (author's transl)].
Tanaka N
Rinsho Byori; 1976; 24(6):432-8. PubMed ID: 988260
[No Abstract] [Full Text] [Related]
75. Pseudosarcomatous myofibroblastic proliferation in urinary bladder.
Roy A; Pramanik RN; Biswas S; Banerjee TJ; Sarkar PK; Sanyal S
J Indian Med Assoc; 1993 Jan; 91(1):18-9. PubMed ID: 8491974
[No Abstract] [Full Text] [Related]
76. Correlation of cytology with histopathology and cystoscopy in urinary bladder tumours.
Javali D; Singh SM; Gupta NP; Wadhwa SN
Indian J Cancer; 1981 Dec; 18(4):241-4. PubMed ID: 7341421
[No Abstract] [Full Text] [Related]
77. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
78. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
[TBL] [Abstract][Full Text] [Related]
79. [Quality criteria in urinary cytology for tumor diagnosis].
Fontaniere B; Ranchere-Vince D; Landry JL; Colombel M; Chopin D; Gattegno B
Prog Urol; 2001 Nov; 11(5):867-75. PubMed ID: 11769083
[No Abstract] [Full Text] [Related]
80. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
